Table 1 Baseline characteristics and outcome variables
Characteristics | Intervention (N = 22) | Control (N = 29) |
|---|---|---|
Men | 14 (63.6%) | 20 (69.0%) |
Women | 8 (36.4%) | 9 (31.0%) |
BMI | 28.4 ± 6.6 | 28.2 ± 4.8 |
Smoker | 2 (9.1%) | 2 (6.9%) |
Osteoarthritis | 14 (63.6%) | 16 (55.2%) |
Vertigo / balance disorder | 13 (59.1%) | 15 (51.7%) |
Sensory loss in feet or neck | 6 (27.3%) | 10 (34.5%) |
Number of falls recent year | 1 (0 to 10) | 1 (0 to 4) |
History of fall recent year | 15 (68.2%) | 17 (58.6%) |
Anti-hypertensive use | 15 (68.2%) | 24 (82.8%) |
Statin use | 14 (63.6%) | 11 (37.9%) |
Total number of prescription drugs | 5 (0 to 16) | 4 (0 to 10) |
Outcome variables | ||
PSEO length (mm) | 501.9 ± 112.9 | 486.9 ± 107.0 |
PSEC length (mm) | 1301.7 ± 749.1 | 1121.9 ± 579.7 |
Timed Up & Go (seconds) | 11.2 ± 2.74 | 10.7 ± 2.28 |
Hand grip strength (kg) | 28.5 ± 10.9 | 37.8 ± 10.3 |
FES (score) | 127 (75 to 130) | 129 (51 to 130) |
FES-I (score) | 21 (16 to 42) | 18 (16 to 34) |